霍乱疫苗市场规模、份额和成长分析（按类型、产品类型、给药途径、最终用户、年龄层、通路和地区划分）－2026-2033年产业预测

预计到 2024 年，全球霍乱疫苗市场规模将达到 8,670 万美元，到 2025 年将成长至 9,372 万美元，到 2033 年将成长至 1.7476 亿美元，预测期（2026-2033 年）的复合年增长率为 8.1%。

霍乱主要透过受污染的食物和水传播，仍然是全球面临的重大公共卫生挑战。此疾病的症状包括严重腹泻、脱水和腹痛，以及心搏过速和低血压等全身性併发症。接种疫苗是重要的预防措施，可透过静脉注射、肌肉注射和口服等多种途径增强人体对霍乱弧菌的免疫力。作为一种有效的生物製药，霍乱疫苗在对抗这种与卫生条件差和缺乏安全饮用水密切相关的感染疾病中至关重要。包括世界卫生组织（世卫组织）在内的国际卫生组织持续推广疫苗接种，将其作为控制霍乱疫情和增强受影响地区公共卫生韧性的关键策略。

全球霍乱疫苗市场成长要素

全球霍乱疫苗市场预计将因多种因素而成长，包括疫苗研发领域的创新方法以及公众对霍乱预防重要性的认识不断提高。不良的生活习惯，例如卫生条件不佳和食用受污染的食物，也加剧了霍乱疫情的持续蔓延，从而推动了疫苗需求。此外，各国政府卫生机构对疫苗接种计画的日益重视预计也将进一步促进市场扩张。然而，监管机构对新疫苗引进的严格要求以及漫长的核准流程可能会给市场带来挑战。

限制全球霍乱疫苗市场的因素

疫苗研发週期长、监管核准要求严格，可能对全球霍乱疫苗市场的扩张构成重大挑战。这些因素可能延缓新产品上市，最终阻碍对霍乱疫情的快速反应能力。此外，复杂的监管环境也可能抑制创新，阻碍投资。这可能会限制市场的整体成长潜力，并限制霍乱疫区民众获得必要疫苗的机会，进而对全球公共卫生造成潜在影响。

全球霍乱疫苗市场趋势

全球霍乱疫苗市场正经历显着成长，主要受霍乱发病率上升的推动，而霍乱发病率上升与卫生条件差密切相关，尤其是在农村和偏远地区。民众对接种疫苗作为预防霍乱疫情措施重要性的认识不断提高，进一步推动了这一趋势。各国政府和卫生组织正将倡议列为优先事项，以减轻霍乱的影响，进而推动市场需求。此外，疫苗研发和分发策略的持续创新有望提高疫苗的可及性和覆盖率，进一步巩固全球霍乱疫苗的市场环境。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球霍乱疫苗市场规模（按类型及复合年增长率划分）（2026-2033 年）

• 全细胞霍乱弧菌O1（含重组B次单元）
• 灭活的口服 O1 和 O139

全球霍乱疫苗市场规模（按产品和复合年增长率划分）（2026-2033 年）

• Vaxchora
• 杜可乐
• 尚科尔
• 其他产品

全球霍乱疫苗市场规模（依给药途径及复合年增长率划分）（2026-2033 年）

• 注射疫苗
• 口服疫苗

全球霍乱疫苗市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 居家医疗
• 专科诊所
• 其他的

全球霍乱疫苗市场规模（依年龄层划分）及复合年增长率（2026-2033 年）

• 成人
• 儿童

全球霍乱疫苗市场规模（依分销管道划分）及复合年增长率（2026-2033 年）

• 医院药房
• 网路药房
• 零售药房

全球霍乱疫苗市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Valneva SE（France）
• Sanofi（France）
• Emergent BioSolutions（USA）
• EuBiologics（South Korea）
• Shantha Biotechnics（India）
• Hilleman Laboratories（Singapore）
• Astellas Pharma（Japan）
• Incepta Vaccine（Bangladesh）
• Vabiotech（France）
• Bharat Biotech（India）
• Biological E.（India）
• Serum Institute of India（India）
• Panum Institute（Denmark）
• Walter Reed Army Institute of Research（USA）
• National Institutes of Health（NIH）（USA）
• World Health Organization（WHO）（Switzerland）
• Centers for Disease Control and Prevention（CDC）（USA）
• Medecins Sans Frontieres（MSF）（Switzerland）
• PATH（USA）

结论与建议

Global Cholera Vaccines Market size was valued at USD 86.7 Million in 2024 and is poised to grow from USD 93.72 Million in 2025 to USD 174.76 Million by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

Cholera remains a significant global public health challenge, primarily transmitted through contaminated food and water. The disease manifests through symptoms such as severe diarrhea, dehydration, abdominal pain, and systemic complications like rapid heartbeat and low blood pressure. Vaccination serves as an essential preventive measure, facilitating the body's immunity against the cholera bacteria through various administration methods, including intravenous, intramuscular, and oral. As a viable biological preparation, the cholera vaccine is pivotal in combating this infectious disease, which is closely linked to poor sanitation and access to safe drinking water. Global health organizations, including the World Health Organization, continue to advocate for vaccination as a crucial strategy to mitigate cholera outbreaks and enhance public health resilience in affected regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholera Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cholera Vaccines Market Segments Analysis

Global Cholera Vaccines Market is segmented by Type, Product, Route of Administration, End User, Age Group, Distribution Channel and region. Based on Type, the market is segmented into Whole Cell V. Cholerae O1 with Recombinant B- subunit and Killed Oral O1 and O139. Based on Product, the market is segmented into Vaxchora, Dukoral, Shanchol and Other Products. Based on Route of Administration, the market is segmented into Injectables Vaccines and Oral Vaccines. Based on End User, the market is segmented into Hospitals, Homecare, Specialty Clinics and Others. Based on Age Group, the market is segmented into Adults and Children. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Online Pharmacy and Retail Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cholera Vaccines Market

The global cholera vaccines market is poised for growth due to a combination of factors, including innovative approaches to vaccine development and heightened public awareness regarding the importance of cholera prevention. Unhealthy lifestyle choices, such as inadequate sanitation and the consumption of contaminated food, further contribute to the ongoing challenge of cholera outbreaks, thereby driving demand for vaccines. Additionally, increased emphasis on immunization initiatives by governmental health organizations is expected to further enhance market expansion. However, the market could face challenges from stringent regulatory requirements and extended approval processes imposed by authorities overseeing new vaccine introductions.

Restraints in the Global Cholera Vaccines Market

The extended time required for vaccine development, combined with the necessity for rigorous regulatory approvals, may pose significant challenges to the expansion of the global cholera vaccines market. These factors can create delays in bringing new products to market, ultimately hampering the ability to respond swiftly to cholera outbreaks. Additionally, navigating the complex landscape of regulatory compliance can impede innovation and discourage investment. As a result, the overall growth potential for the market may be restrained, limiting access to much-needed vaccination options for regions highly affected by cholera and affecting public health outcomes globally.

Market Trends of the Global Cholera Vaccines Market

The global cholera vaccines market is experiencing significant growth, propelled by the rising incidence of cholera linked to inadequate sanitation and hygiene conditions, particularly in rural and isolated regions. This trend is further fueled by heightened public awareness surrounding the importance of vaccination as a preventive measure against cholera outbreaks. Governments and health organizations are increasingly prioritizing vaccination initiatives to mitigate the disease's impact, thus enhancing market demand. Additionally, ongoing innovations in vaccine development and distribution strategies are expected to expand access and outreach, fostering a more robust market environment for cholera vaccines globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cholera Vaccines Market Size by Type & CAGR (2026-2033)

• Market Overview
• Whole Cell V. Cholerae O1 with Recombinant B- subunit
• Killed Oral O1 and O139

Global Cholera Vaccines Market Size by Product & CAGR (2026-2033)

• Market Overview
• Vaxchora
• Dukoral
• Shanchol
• Other Products

Global Cholera Vaccines Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Injectables Vaccines
• Oral Vaccines

Global Cholera Vaccines Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Homecare
• Specialty Clinics
• Others

Global Cholera Vaccines Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Adults
• Children

Global Cholera Vaccines Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Cholera Vaccines Market Size & CAGR (2026-2033)

• North America (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Valneva SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EuBiologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shantha Biotechnics (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hilleman Laboratories (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Incepta Vaccine (Bangladesh)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vabiotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological E. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panum Institute (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walter Reed Army Institute of Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• National Institutes of Health (NIH) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• World Health Organization (WHO) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Centers for Disease Control and Prevention (CDC) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medecins Sans Frontieres (MSF) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PATH (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations